CIK 0001205922 · Non-accelerated filer<br>Smaller reporting company
VACCINEX, INC.
Sign in to watch- Ticker
- VCNX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161603202
- Phone
- 585-271-2700
- Business address
- 1895 MOUNT HOPE AVE, ROCHESTER, NY, 14620
- Former names
- VACCINEX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-03 | FRIEDBERG ALBERT Director | Purchase · Warrant (Right to Buy) | +3,000,000 | $1.00 | $3.0M | 3,000,000 |
| 2023-09-29 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +11,291 | $0.77 | $9K | 11,291 |
| 2023-09-22 | Zauderer Maurice President and CEO | Grant or award | +2,051,282 | $0.16 | $320K | 7,193,973 |
| 2023-06-30 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +2,414 | $3.62 | $9K | 2,414 |
| 2023-05-15 | FRIEDBERG ALBERT Director | Grant or award | +6,711,552 | $0.37 | $2.5M | 26,216,904 |
| 2023-05-11 | Stecyk Chrystyna Bedrij Director | Grant or award · Stock Option (Right to Buy) | +143,848 | 143,848 | ||
| 2023-05-11 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +143,848 | 143,848 | ||
| 2023-05-11 | MANIAN BALA S Director | Grant or award · Stock Option (Right to Buy) | +143,848 | 143,848 | ||
| 2023-05-11 | Yanni Barbara Director | Grant or award · Stock Option (Right to Buy) | +143,848 | 143,848 | ||
| 2023-05-11 | Van Strydonck, Gerald E. Director | Grant or award · Stock Option (Right to Buy) | +143,848 | 143,848 | ||
| 2023-03-31 | Leonard John E. SVP, Development | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2023-03-31 | Evans Elizabeth E. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-03-31 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +32,107 | $0.27 | $9K | 32,107 |
| 2023-03-31 | FRIEDBERG ALBERT Director | Grant or award | +4,146,341 | $0.41 | $1.7M | 19,505,352 |
| 2023-03-31 | Smith Ernest S. SVP, Research & CSO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-03-31 | Royer Scott E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2023-03-31 | Zauderer Maurice President and CEO | Grant or award | +731,707 | $0.41 | $300K | 5,142,691 |
| 2023-03-31 | Zauderer Maurice President and CEO | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2022-12-31 | Frieberg Jacob B. Director | Grant or award · Stock Option (Right to Buy) | +19,852 | $0.44 | $9K | 19,852 |
| 2022-12-06 | Zauderer Maurice President and CEO | Other acquisition | +3,988 | 181,736 |
Page 4 of 8 · 146 trades